ATG16L1 T300A Polymorphism is Correlated with Gastric Cancer Susceptibility

Pathology and Oncology Research

Volumn 22, Issue 2, 2016, Pages 317-322

  Burada, Florin ^a   Ciurea, Marius Eugen ^a   Nicoli, Raluca ^a   Streata, Ioana ^a   Vilcea, Ionica Dan ^a   Rogoveanu, Ion ^a   Ioana, Mihai ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

ATG16L1 gene; Autophagy; Gastric cancer; Gene expression; Polymorphism

Indexed keywords

ADULT; ALLELE; ARTICLE; AUTOPHAGY; CANCER CLASSIFICATION; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENDOSCOPY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; UPREGULATION; AGED; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR;

ATG16L1 PROTEIN, HUMAN; AUTOPHAGY RELATED PROTEIN;

AGED; AUTOPHAGY-RELATED PROTEINS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84961214933     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-015-0006-9     Document Type: Article

References (25)

1. Arnold M, Karim-Kos HE, Coebergh JW, Byrnes G, Antilla A, Ferlay J, Renehan AG, Forman D, Soerjomataram I (2015) Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European cancer observatory. Eur J Cancer 51(9):1164–1187. doi:10.1016/j.ejca.2013.09.002
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403. doi:10.1016/j.ejca.2012.12.027
3. Polk DB, Peek Jr RM (2010) Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10(6):403–414. doi:10.1038/nrc2857
4. Biological agents. Volume 100 B. A review of human carcinogens (2012). IARC Monogr Eval Carcinog Risks Hum 100 (Pt B):1–441
5. Sepulveda AR (2013) Helicobacter, inflammation, and gastric cancer. Curr Pathobiol Rep 1(1):9–18. doi:10.1007/s40139-013-0009-8
6. Cid TP, Fernandez MC, Benito Martinez S, Jones NL (2013) Pathogenesis of Helicobacter pylori infection. Helicobacter 18(Suppl 1):12–17. doi:10.1111/hel.12076
7. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132(1):27–42. doi:10.1016/j.cell.2007.12.018
8. Weidberg H, Shvets E, Elazar Z (2011) Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem 80:125–156. doi:10.1146/annurev-biochem-052709-094552
9. Levine B, Mizushima N, Virgin HW (2011) Autophagy in immunity and inflammation. Nature 469(7330):323–335. doi:10.1038/nature09782
10. Fujita N, Itoh T, Omori H, Fukuda M, Noda T, Yoshimori T (2008) The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell 19(5):2092–2100. doi:10.1091/mbc.E07-12-1257
11. Brest P, Corcelle EA, Cesaro A, Chargui A, Belaid A, Klionsky DJ, Vouret-Craviari V, Hebuterne X, Hofman P, Mograbi B (2010) Autophagy and crohn’s disease: at the crossroads of infection, inflammation, immunity, and cancer. Curr Mol Med 10(5):486–502
12. Zheng H, Ji C, Li J, Jiang H, Ren M, Lu Q, Gu S, Mao Y, Xie Y (2004) Cloning and analysis of human Apg16L. DNA Seq 15(4):303–305
13. Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJ, Campbell BJ, Jewell D, Simmons A (2010) NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 16(1):90–97. doi:10.1038/nm.2069
14. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J, Gunther S, Prescott NJ, Onnie CM, Hasler R, Sipos B, Folsch UR, Lengauer T, Platzer M, Mathew CG, Krawczak M, Schreiber S (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for crohn disease in ATG16L1. Nat Genet 39(2):207–211. doi:10.1038/ng1954
15. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffiths AM, Targan SR, Ippoliti AF, Bernard EJ, Mei L, Nicolae DL, Regueiro M, Schumm LP, Steinhart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, Brant SR (2007) Genome-wide association study identifies new susceptibility loci for crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39(5):596–604. doi:10.1038/ng2032
16. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (2007). Nature 447 (7145):661–678. doi:10.1038/nature05911
17. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, Nelson DA, Jin S, White E (2006) Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10(1):51–64. doi:10.1016/j.ccr.2006.06.001
18. Greenfield LK, Jones NL (2013) Modulation of autophagy by Helicobacter pylori and its role in gastric carcinogenesis. Trends Microbiol 21(11):602–612. doi:10.1016/j.tim.2013.09.004
19. Terebiznik MR, Raju D, Vazquez CL, Torbricki K, Kulkarni R, Blanke SR, Yoshimori T, Colombo MI, Jones NL (2009) Effect of Helicobacter pylori’s vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy 5(3):370–379
20. Raju D, Hussey S, Ang M, Terebiznik MR, Sibony M, Galindo-Mata E, Gupta V, Blanke SR, Delgado A, Romero-Gallo J, Ramjeet MS, Mascarenhas H, Peek RM, Correa P, Streutker C, Hold G, Kunstmann E, Yoshimori T, Silverberg MS, Girardin SE, Philpott DJ, El Omar E, Jones NL (2012) Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 142(5):1160–1171. doi:10.1053/j.gastro.2012.01.043
21. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, Omori H, Noda T, Yamamoto N, Komatsu M, Tanaka K, Kawai T, Tsujimura T, Takeuchi O, Yoshimori T, Akira S (2008) Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456(7219):264–268. doi:10.1038/nature07383
22. Huijbers A, Plantinga TS, Joosten LA, Aben KK, Gudmundsson J, den Heijer M, Kiemeney LA, Netea MG, Hermus AR, Netea-Maier RT (2012) The effect of the ATG16L1 Thr300Ala polymorphism on susceptibility and outcome of patients with epithelial cell-derived thyroid carcinoma. Endocr Relat Cancer 19(3):L15–L18. doi:10.1530/erc-11-0302
23. Lassen KG, Kuballa P, Conway KL, Patel KK, Becker CE, Peloquin JM, Villablanca EJ, Norman JM, Liu TC, Heath RJ, Becker ML, Fagbami L, Horn H, Mercer J, Yilmaz OH, Jaffe JD, Shamji AF, Bhan AK, Carr SA, Daly MJ, Virgin HW, Schreiber SL, Stappenbeck TS, Xavier RJ (2014) Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. Proc Natl Acad Sci U S A 111(21):7741–7746. doi:10.1073/pnas.1407001111
24. Kuballa P, Huett A, Rioux JD, Daly MJ, Xavier RJ (2008) Impaired autophagy of an intracellular pathogen induced by a crohn’s disease associated ATG16L1 variant. PLoS One 3(10):e3391. doi:10.1371/journal.pone.0003391
25. Grimm WA, Messer JS, Murphy SF, Nero T, Lodolce JP, Weber CR, Logsdon MF, Bartulis S, Sylvester BE, Springer A, Dougherty U, Niewold TB, Kupfer SS, Ellis N, Huo D, Bissonnette M, Boone DL (2015) The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. Gut. doi:10.1136/gutjnl-2014-308735